ABIONYX Pharma SA (EPA:ABNX)
France flag France · Delayed Price · Currency is EUR
3.540
-0.050 (-1.39%)
Apr 28, 2026, 5:35 PM CET

ABIONYX Pharma Market Cap

ABIONYX Pharma has a market cap or net worth of €124.88 million as of April 28, 2026. Its market cap has increased by 203.65% in one year.

Market Cap
124.88M
Enterprise Value
125.63M
Revenue
4.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.54

Market Cap Chart

Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 124.88M, a decrease of -41.69%. That is a compound annual growth rate of -4.75%.

History

DateMarket Cap% Change
Apr 28, 2026124.88M-6.47%
Dec 31, 2025133.53M223.58%
Dec 31, 202441.27M-0.54%
Dec 29, 202341.49M-14.37%
Dec 30, 202248.45M-28.38%
Dec 31, 202167.65M178.53%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Innate Pharma 105.09M
MaaT Pharma 102.89M
Adocia 90.87M
Sensorion 194.82M
Transgene 207.33M
Valerio Therapeutics Société anonyme 76.26M
OSE Immunotherapeutics 67.80M
Cellectis 239.99M
Market Cap Rankings